β-eye: A benchtop system for in vivo molecular screening of labeled compounds

E Fysikopoulos,M Rouchota,M Georgiou,C Sfyris,N Cheimarios,S Sarpaki,S Kostopoulos,D Glotsos,B Larimer,C Hunter,S Lapi,H Houson,A V F Massicano,A Sorace,E Lamprou,G Loudos

DOI: https://doi.org/10.1016/j.apradiso.2021.110034

Abstract:Preclinical nuclear molecular imaging speeds up the mean time from synthesis to market, in drug development process. Commercial imaging systems have in general high cost, require high-cost service contracts, special facilities and trained staff. In the current work, we present β-eye, a benchtop system for in vivo molecular screening of labeled compounds with Positron Emission Tomography (PET) isotopes. The developed system is based on a dual-head geometry, offering simplicity and decreased cost. The goal of the design is to provide 2D, real-time radionuclide images of mice, allowing the recording of fast frames and thus perform fast kinetic studies, with spatial resolution of ∼2 mm. Performance evaluation demonstrates the ability of β-eye to provide quantitative results for injected activities lower than 1.5 MBq, which is adequate for pharmacodynamic studies in small mice.